Novoeight Kit
Product Images NDC 0169-7820

Product Visual Gallery

This gallery contains 41 technical images submitted to the FDA as part of the official labeling for Novoeight (NDC 0169-7820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novo Nordisk, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Export 00

Packaging label for Novoeight 3000 IU, a kit containing antihemophilic factor (recombinant) by Novo Nordisk. The label includes dosage strength, usage instructions for intravenous administration after reconstitution, a list number, and illustrates contents including a vial adapter and pre-filled diluent syringe. The label emphasizes single dose use and no preservatives.*

FDA Label Image

Export 01

Packaging label for Novoeight 2000 IU, an antihemophilic factor recombinant in KIT dosage form by Novo Nordisk. The label shows the proprietary and generic names, strength (2000 IU), usage details for intravenous use after reconstitution, and inclusion of MixPro vial adapter and pre-filled diluent syringe. The label also displays the NDC 0169-7820-01 and manufacturer logo.*

FDA Label Image

Export 02

Packaging label for Novoeight, an antihemophilic factor recombinant kit with a strength of 1500 IU. The label shows the product name, dosage form as a kit, and includes NDC 0169-7815-01. It is a prescription product from Novo Nordisk and contains a vial adapter and pre-filled diluent syringe. The label also includes usage instructions and barcode.*

FDA Label Image

Export 03

NOVOEIGHT 1000 IU kit packaging label for antihemophilic factor recombinant, a plasma derivative by Novo Nordisk. The label shows product name, strength, dosage form as kit, NDC number, and includes instructions for intravenous use after reconstitution. It also depicts a vial and pre-filled diluent syringe included in the kit.*

FDA Label Image

Export 04

Packaging label for NovoEight 500 IU Kit containing antihemophilic factor recombinant. The kit is for intravenous use and includes a vial adapter and pre-filled diluent syringe. The label displays the Novo Nordisk logo and emphasizes a single-dose, preservative-free formulation, with directions for reconstitution and use. The NDC number 0169-7850-01 is shown clearly.*

FDA Label Image

Export 05

NOVOEIGHT 250 IU kit packaging label for antihemophilic factor recombinant. The label shows the proprietary name Novoeight, the strength of 250 IU, and the dosage form as a kit. It includes usage instructions for intravenous use after reconstitution, noting it is single dose with no preservatives. The label also mentions it contains MixPro, including a vial adapter and pre-filled diluent syringe. The labeler is Novo Nordisk.*

FDA Label Image

Overview (Image 01)

An assembly diagram showing components of the NOVOEIGHT kit labeled as vial with NovoEight powder, vial adapter, pre-filled syringe with diluent, and plunger rod. Each component is detailed with parts such as plastic cap, rubber stopper on vial, spike and protective caps on vial adapter, syringe tip and rubber plunger on pre-filled syringe, and a threaded plunger rod with wide top end.*

FDA Label Image

Figure A (Image 02)

An instructional illustration showing two hands preparing medication with a vial and a syringe. The left hand holds a vial upright, while the right hand holds a syringe needle positioned near the vial, suggesting preparation for injection or medication reconstitution.*

FDA Label Image

Figure B (Image 03)

An instructional illustration showing a hand holding a device or component labeled with the letter B, likely part of a preparation or administration process for a medication kit. The image emphasizes grip or handling technique.*

FDA Label Image

Figure C (Image 04)

An instructional illustration showing hands peeling open a blister pack with a tab being lifted upward to access the contents inside. The image demonstrates the proper way to open the packaging, likely for a medical or pharmaceutical product.*

FDA Label Image

Figure D (Image 05)

An instructional illustration showing a hand inserting a syringe or similar device downward into a vial, indicated by a blue downward arrow. The image likely demonstrates a step in the preparation or administration process of the NOVOEIGHT antihemophilic factor recombinant kit by Novo Nordisk.*

FDA Label Image

Figure E (Image 06)

An instructional diagram showing a hand removing the cap from a vial or bottle. The close-up inset highlights the cap being pulled upward, indicating the proper technique for vial cap removal, likely as part of the preparation process for the NOVOEIGHT antihemophilic factor recombinant kit from Novo Nordisk.*

FDA Label Image

Fig. F (Image 07)

An instructional illustration showing hands holding a syringe and inserting the needle into a vial or similar container, with an upward arrow indicating a pulling motion. The image is likely part of a dosing or preparation guide related to the NOVOEIGHT antihemophilic factor recombinant kit.*

FDA Label Image

Figure G (Image 08)

An instructional illustration showing hands holding a vial and a syringe, demonstrating how to connect or prepare the components for reconstitution or administration.*

FDA Label Image

Figure H (Image 09)

An instructional diagram showing hands opening a component by unscrewing a cap or lid in an upward motion. The image is likely part of a step-by-step guide for preparing or assembling the NOVOEIGHT antihemophilic factor recombinant kit.*

FDA Label Image

Figure I (Image 10)

Instructional illustration showing a hand holding a syringe or injection device and an arrow indicating a directional motion, likely demonstrating a step for preparing or using the NOVOEIGHT antihemophilic factor recombinant kit.*

FDA Label Image

Figure J (Image 11)

An instructional illustration showing a hand holding a syringe-like device labeled NOVOEIGHT antihemophilic factor recombinant kit, with an arrow indicating to rotate or twist a part of the device, likely demonstrating preparation or mixing steps before use.*

FDA Label Image

Figure K (Image 12)

Instructional illustration showing a hand holding a syringe with an arrow pointing downward, indicating a step in the use or preparation of a medication, likely part of a kit such as NOVOEIGHT antihemophilic factor recombinant.*

FDA Label Image

Overview (Image 13)

An instructional diagram showing kit components for NOVOEIGHT antihemophilic factor recombinant. It includes a vial with Novoeight powder sealed with a plastic cap and rubber stopper, a vial adapter with a spike and protective cap, a pre-filled syringe with diluent featuring a syringe tip, rubber plunger, scale, and syringe cap, and a plunger rod with a thread and wide top end.*

FDA Label Image

Figure A (Image 14)

An instructional illustration showing hands holding a vial and a syringe, demonstrating proper preparation or handling technique for a Novo Nordisk product kit. The image is part of a step-by-step guide for using the NOVOEIGHT antihemophilic factor recombinant KIT.*

FDA Label Image

Figure B (Image 15)

An instructional illustration showing a hand holding a vial with the thumb pushing upward on the vial's stopper, indicating how to open or activate the vial for use. This image is part of the NOVOEIGHT antihemophilic factor recombinant kit instructions by Novo Nordisk.*

FDA Label Image

Fig. C (Image 16)

An instructional illustration showing a hand pulling an object upward from a small container or vial. The image appears to demonstrate part of the preparation or usage process for a medical product, likely related to the NOVOEIGHT antihemophilic factor recombinant kit by Novo Nordisk.*

FDA Label Image

Figure D (Image 17)

An instructional illustration depicting a hand placing a cap or stopper onto a vial, indicated by a downward arrow. The image likely forms part of assembly or preparation instructions for a pharmaceutical kit, showing how to secure the vial lid properly.*

FDA Label Image

Fig. E (Image 18)

An instructional diagram illustrating the removal of a protective cap from a vial by lifting it upwards with the fingers, shown with a close-up inset of the vial cap. The image is likely part of a preparation guide for the NOVOEIGHT antihemophilic factor recombinant kit by Novo Nordisk.*

FDA Label Image

Fig. F (Image 19)

An instructional illustration showing two hands holding a syringe or similar medical device, demonstrating a twisting motion with a curved arrow indicating to turn a part of the device. The image appears to be part of a step-by-step guide for assembling or using the kit components.*

FDA Label Image

Fig. G (Image 20)

An instructional illustration showing a hand removing the cap from a small vial or container, indicating preparation for use or assembly in a medication kit.*

FDA Label Image

Fig. H (Image 21)

An instructional illustration showing two hands connecting or assembling two parts of a medical device or kit, with an upward arrow indicating the direction of movement. The image uses simple line art with a blue border and a letter 'H' in the top left corner, suggesting it is step H in a sequence.*

FDA Label Image

Fig. I (Image 22)

Instructional illustration showing a hand holding a syringe and a vial, demonstrating the process of drawing fluid from the vial into the syringe by pulling the plunger upward, with a directional arrow indicating the movement.*

FDA Label Image

Fig J (Image 23)

An instructional illustration showing a hand holding a syringe with an arrow indicating a twisting motion at the syringe tip. The image appears to demonstrate how to attach or secure the syringe to another component, relevant to preparation or administration steps for a medication kit.*

FDA Label Image

I (Image 24)

Packaging label for NOVOEIGHT, an antihemophilic factor recombinant plasma derivative kit. The label includes the proprietary and nonproprietary names, depicts use for hemophilia, and shows branding by Novo Nordisk. The design features images of the kit components and Novo Nordisk logo.*

FDA Label Image

Figure K (Image 25)

Illustration showing a hand holding a syringe with a vial attached at the tip. A downward arrow below the syringe suggests pressing down or pushing liquid through the syringe. The background is light blue with a small 'K' in the top left corner.*

FDA Label Image

Fig. L (Image 26)

An instructional illustration showing hands assembling or connecting parts of a medical device, likely related to the preparation or use of the NOVOEIGHT antihemophilic factor recombinant kit. The image includes an arrow indicating a rotation or attachment step on the equipment labeled with an 'L'.*

FDA Label Image

Fig. M (Image 27)

An instructional diagram showing the step to add a small vial's contents into a larger round container or device, indicated by an arrow pointing from the vial to the container with multiple small compartments or slots. This likely illustrates part of the preparation or reconstitution process for the medication NovoEight antihemophilic factor recombinant kit by Novo Nordisk.*

FDA Label Image

250 Iu Vial Label (Image 34)

Label for NOVOEIGHT 250 IU antihemophilic factor recombinant kit by Novo Nordisk. The label includes reconstitution instructions with 4 mL sodium chloride solution and storage directions to keep in a refrigerator at 36°F to 46°F (2°C to 8°C). The label states Rx Only and advises not to freeze.*

FDA Label Image

500 Iu Vial (Image 35)

Label for Novoeight 500 IU kit containing antihemophilic factor recombinant. The label includes storage instructions to keep refrigerated at 36°F to 46°F (2 to 8°C) and notes reconstitution with 4 mL sodium chloride solution. It states Rx only and lists the labeler as Novo Nordisk Inc.*

FDA Label Image

1000 Iu Vial (Image 36)

Packaging label for NOVOEIGHT kit containing antihemophilic factor recombinant. The label indicates 1000 IU strength, instructions for reconstitution with 4 mL sodium chloride solution, storage in a refrigerator at 36°F - 46°F (2-8°C), and is marked Rx Only. Manufactured by Novo Nordisk Inc. Contact information includes 1-844-30-EIGHT.*

FDA Label Image

1500 Iu Vial (Image 37)

NOVOEIGHT 1500 IU kit packaging label showing the antihemophilic factor recombinant. The label indicates storage in a refrigerator at 36°F-46°F (2-8°C) and instructions for reconstitution with 4 mL sodium chloride solution. The product is Rx only and manufactured by Novo Nordisk.*

FDA Label Image

2000 Iu Vial (Image 38)

Label for NOVOEIGHT antihemophilic factor recombinant, a plasma derivative kit by Novo Nordisk. It includes the dosage strength of 2000 IU, instructions specifying reconstitution with 4 mL sodium chloride solution, refrigeration storage at 36°F-46°F (2-8°C), and a caution not to freeze. The label also indicates it is for prescription use only.*

FDA Label Image

3000 Iu Vial (Image 39)

NOVOEIGHT 3000 IU kit label for antihemophilic factor recombinant. The label includes storage instructions to keep refrigerated at 36°F to 46°F (2°C to 8°C), and directions for reconstitution with 4 mL sodium chloride solution. The label also displays the labeler as Novo Nordisk and notes that the product is for prescription use only.*

FDA Label Image

Syringe Label (Image 40)

Label for Sodium Chloride Solution 4 mL vial for reconstitution of Novoeight, an antihemophilic factor recombinant. The label includes storage instructions (refrigerate 2°C to 8°C, do not freeze), single-use designation, and manufacturer information Novo Nordisk Inc. It also shows a barcode and space for expiry date and lot number.*

FDA Label Image

Symbol (Image 41)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.